» Articles » PMID: 23771926

New Genes in Bone Development: What's New in Osteogenesis Imperfecta

Overview
Specialty Endocrinology
Date 2013 Jun 18
PMID 23771926
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Osteogenesis imperfecta (OI) is a heritable bone dysplasia characterized by bone fragility and deformity and growth deficiency. Most cases of OI (classical types) have autosomal dominant inheritance and are caused by mutations in the type I collagen genes. During the past several years, a number of noncollagenous genes whose protein products interact with collagen have been identified as the cause(s) of rare forms of OI. This has led to a paradigm shift for OI as a collagen-related condition. The majority of the non-classical OI types have autosomal recessive inheritance and null mutations in their respective genes. The exception is a unique dominant defect in IFITM5, which encodes Bril and leads to hypertrophic callus and interosseous membrane ossification. Three recessive OI types arise from defects in any of the components of the collagen prolyl 3-hydroxylation complex (CRTAP, P3H1, CyPB), which modifies the collagen α1(I)Pro986 residue. Complex dysfunction leads to delayed folding of the procollagen triple helix and increased helical modification. Next, defects in collagen chaperones, HSP47 and FKBP65, lead to improper procollagen folding and deficient collagen cross-linking in matrix, respectively. A form of OI with a mineralization defect is caused by mutations in SERPINF1, whose protein product, PEDF, is a well-known antiangiogenesis factor. Defects in the C-propeptide cleavage enzyme, BMP1, also cause recessive OI. Additional genes, including SP7 and TMEM38B, have been implicated in recessive OI but are as yet unclassified. Elucidating the mechanistic pathways common to dominant and recessive OI may lead to novel therapeutic approaches to improve clinical manifestations.

Citing Articles

RNA-Binding Proteins as Novel Effectors in Osteoblasts and Osteoclasts: A Systems Biology Approach to Dissect the Transcriptional Landscape.

Meshcheryakova A, Bohdan S, Zimmermann P, Jaritz M, Pietschmann P, Mechtcheriakova D Int J Mol Sci. 2024; 25(19).

PMID: 39408753 PMC: 11476634. DOI: 10.3390/ijms251910417.


TMEM38B Gene Mutation Associated With Osteogenesis Imperfecta.

Sobaihi M, Habiballah A, Habib A Cureus. 2024; 16(9):e69021.

PMID: 39385871 PMC: 11463972. DOI: 10.7759/cureus.69021.


Root resorption of primary molars and dental development of premolars in children with Osteogenesis Imperfecta medicated with bisphosphonates, grouped according to age and gender.

Garcete Delvalle C, De Nova Garcia M, Mourelle Martinez M BMC Oral Health. 2024; 24(1):857.

PMID: 39069613 PMC: 11283712. DOI: 10.1186/s12903-024-04557-3.


Molecular Genetic Diagnosis with Targeted Next Generation Sequencing in a Cohort of Turkish Osteogenesis Imperfecta Patients and their Genotype-phenotype Correlation.

Ozen S, Goksen D, Evin F, Isik E, Onay H, Akgun B J Clin Res Pediatr Endocrinol. 2024; 16(4):431-442.

PMID: 38828893 PMC: 11629724. DOI: 10.4274/jcrpe.galenos.2024.2022-12-8.


Rare coexistence of hypopituitarism with osteogenesis imperfecta - A double-trouble for bone.

Basu R, Goswami S, Sengupta N, Baidya A, Mondal S, Swapnil K Bone Rep. 2024; 21:101768.

PMID: 38706521 PMC: 11068520. DOI: 10.1016/j.bonr.2024.101768.


References
1.
Forlino A, Cabral W, Barnes A, Marini J . New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7(9):540-57. PMC: 3443407. DOI: 10.1038/nrendo.2011.81. View

2.
Volodarsky M, Markus B, Cohen I, Staretz-Chacham O, Flusser H, Landau D . A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta. Hum Mutat. 2013; 34(4):582-6. DOI: 10.1002/humu.22274. View

3.
Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J . A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet. 2012; 91(2):349-57. PMC: 3415541. DOI: 10.1016/j.ajhg.2012.06.011. View

4.
Alanay Y, Avaygan H, Camacho N, Utine G, Boduroglu K, Aktas D . Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2010; 86(4):551-9. PMC: 2850430. DOI: 10.1016/j.ajhg.2010.02.022. View

5.
Hosomichi J, Yasui N, Koide T, Soma K, Morita I . Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor. Biochem Biophys Res Commun. 2005; 335(3):756-61. DOI: 10.1016/j.bbrc.2005.07.140. View